CTSN PRIMARY Trial (Mitral Valve Regurgitation) - Clinical Trial

Email to Participate

shelly.fincannon@duke.edu

¿Cuál es el Propósito de este estudio?

We are doing this study to compare treatment options for mitral valve regurgitation.

¿Cuál es la Condición que se está estudiando?

Mitral Valve Regurgitation (MR)

¿Quién puede participar en el Estudio?

Adults with mitral valve regurgitation who plan to have it repaired.

For more information about who can join this study, contact the study team at shelly.fincannon@duke.edu.

Grupo etario

Adultos

¿Qué Implica?

Si decide unirse a este estudio, recibirá una asignación aleatoria (como lanzar una moneda al aire) a 1 de 2 grupos:

Group 1: you will have mitral valve surgery, performed in an operating room by a cardiac surgeon
Group 2: you will have transcatheter edge-to-edge repair, performed in a cardiac catheterization laboratory by an interventional cardiologist

Participants assigned to both groups will also:

Have echocardiograms
Complete a six-minute walk test
Responder encuestas

If you do not want to be part of the study that randomly assigns you to treatment, you can participate in a registry. If you join the registry, we will collect data from your medical records related to your treatment for MR so we can learn more about the condition and its treatment outcomes.